CramX Logo
Johnson & Johnson - GB 540 Economics For Global Decision Makers - Document preview page 1

Johnson & Johnson - GB 540 Economics For Global Decision Makers - Page 1

Document preview content for Johnson & Johnson - GB 540 Economics For Global Decision Makers

Johnson & Johnson - GB 540 Economics For Global Decision Makers

This Project PPT provides an economic analysis of Johnson & Johnson�s strategies in global markets.

Daniel Kim
Contributor
4.9
0
12 months ago
Preview (12 of 37 Pages)
100%
Log in to unlock
Page 1 of 12
Johnson & Johnson - GB 540 Economics For Global Decision Makers - Page 1 preview imageJohnson & JohnsonBill JusticeGB 540 Economics for Global Decision MakersInternationalEconomic and Emerging Economies-Final ProjectNovember 23, 2010
Page 2 of 12
Johnson & Johnson - GB 540 Economics For Global Decision Makers - Page 2 preview image
Page 3 of 12
Johnson & Johnson - GB 540 Economics For Global Decision Makers - Page 3 preview imageCompany HistoryFounded in 1885, New Brunswick, NJBy the Johnson brothers Robert, James,and EdwardStarted with 14 employees in a formerwallpaper factoryFirst product was surgical dressings
Page 4 of 12
Johnson & Johnson - GB 540 Economics For Global Decision Makers - Page 4 preview imageCompany OverviewThe world's largest healthcare groupR&D, manufacture, and sale of a range of products in the healthcarefieldOperates in three segments: Consumer, Pharmaceutical, and MedicalDevices and Diagnostics115,000 employees worldwideMore than 250 operating companiesSell products in 60 countries throughout the world
Page 5 of 12
Johnson & Johnson - GB 540 Economics For Global Decision Makers - Page 5 preview imageProduct CategoriesAllergiesBaby CareDental CareDiabetes CareFeminine HygieneGastrointestinalNutritionalOrthopedicsPrescription DrugsVision CareWound CareColds and FluCardiologyDenture CareFamily PlanningFirst AidMedial Devices/DiagnosticsOncologyPain RelieverSkin and Hair CareWomen’s Health
Page 6 of 12
Johnson & Johnson - GB 540 Economics For Global Decision Makers - Page 6 preview imageCorporate Leadership
Page 7 of 12
Johnson & Johnson - GB 540 Economics For Global Decision Makers - Page 7 preview imageManagementWeldon Williams-(1971) CEOJoined the company in 1971Served in several sales, marketing and international management positionsDominic Caruso-(1999) CFO & Vice President of FinancePreviously VP of the Finance for the Medical Devices and DiagnosticsKPMGJoined in October of 1999 through the acquisition of Centocor (has been with that company since1985)Russell C. Deyo-(1985) Vice President, Human Resources and GeneralCounselJoined the company in 1985 as a general attorneyPreviously VP of Administration, named to post in 1996Appointed to General Counsel in April 2004Given additional responsibility for Human Resources in 2009Strong Sense of Seniority
Page 8 of 12
Johnson & Johnson - GB 540 Economics For Global Decision Makers - Page 8 preview imageCurrent Financial Status
Page 9 of 12
Johnson & Johnson - GB 540 Economics For Global Decision Makers - Page 9 preview imageHighlightsA stable and strong company that meets all the needs of astock an investor should have going into a recessionDIVERSIFICATION-not only produces medication, but alsomedical equipment, and human staple goodsUnlike many other pharmaceutical companies, they are notin big trouble with patentsProven successful during the recent recessions
Page 10 of 12
Johnson & Johnson - GB 540 Economics For Global Decision Makers - Page 10 preview imagePerformance in 2001RecessionHad a 2:1 stock split during the recessionPerformance in Past RecessionJNJ Adjusted CloseDJIA
Page 11 of 12
Johnson & Johnson - GB 540 Economics For Global Decision Makers - Page 11 preview imageTrack Record of PerformanceExceptionally consistent performance75 consecutive years of sales increases24 consecutive years of earnings increases45 consecutive years of dividend increasesFew, if any companies, can claim this
Page 12 of 12
Johnson & Johnson - GB 540 Economics For Global Decision Makers - Page 12 preview imageJNJ Common StockJohnson & Johnson Common Stock(NYSE: JNJ )After Hours: 63.85 0.02 (0.03%) 7:58PMESTLast Trade:63.83Trade Time:Nov 19Change:0.00 (0.00%)Prev Close:63.83Open:63.89Bid:63.72 x 300Ask:63.95 x 2001y Target Est:67.84Day's Range:63.65-64.2252wk Range:56.86-66.20Volume:12,890,323Avg Vol (3m):10,326,100Market Cap:175.29BP/E (ttm):13.11EPS (ttm):4.87Div & Yield:2.16 (3.40%)Source: Yahoo Finance
Preview Mode

This document has 37 pages. Sign in to access the full document!